{
    "code": "56029307",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56029307",
    "time": "2021-10-15 08:25:18",
    "許可證字號": "衛部醫器輸字第029307號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD4031",
    "有效日期": "116\/01\/26",
    "發證日期": "106\/01\/26",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05602930700",
    "中文品名": "貝克曼庫爾特協康新苯二氮試劑",
    "英文品名": "BECKMAN COULTER SYNCHRON Systems Benzodiazepine Reagent (BNZG)",
    "效能": "本產品搭配UniCel DxC 600\/800 系統搭配使用SYNCHRON系統藥物濫用測試尿液校正液(DAT)，在閥值在200 ng\/mL (oxazepam)的情況下，定性檢測人類尿液中的苯二氮。",
    "醫器規格": "A18298 (1×250 tests\/kit)，以下空白。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "A臨床化學及臨床毒理學",
    "醫器次類別一": "A3170苯(并)二氮試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "6201027023  美商貝克曼庫爾特有限公司台灣分公司",
    "申請商地址": "台北市大安區敦化南路二段216號8樓",
    "主製造廠": [
        {
            "": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "MUS1066200  BECKMAN COULTER INC.",
            "製造廠廠址": "250 S. KRAEMER BOULEVARD, BREA, CA 92821, U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560293070001-106-04-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56029307&Seq=001&Type=9"
        },
        {
            "title": "560293070002-106-04-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56029307&Seq=001&Type=8"
        }
    ]
}